Xiaobin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaobin Wang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Hongchao Ma
Department of Physiology, Shenzhen University Medical School, Shenzhen, China
60 shared publications - Liang Shi
Department of Physiology, Shenzhen University Medical School, Shenzhen, China
60 shared publications - Maolin Wang
Department of Physiology, Shenzhen University Medical School, Shenzhen, China
60 shared publications - Meiqi Li
Department of Physiology, Shenzhen University Medical School, Shenzhen, China
60 shared publications - Min Jia
Department of Physiology, Shenzhen University Medical School, Shenzhen, China
60 shared publications - Tobias Achu Muluh
Shenzhen University Medical School, Shenzhen University, Shenzhen, China
60 shared publications
Latest Publications
- 6 July 2026
- Published by Springer Nature in Genome Instability & Disease
- Vol. 7 (3) , 13
Epigenetic and DNA-repair programs in corpus cavernosum endothelium: genome stability and erectile dysfunction
- 6 July 2026
- Published by Springer Nature in Genome Instability & Disease
- Vol. 7 (3) , 13
Epigenetic and DNA-repair programs in corpus cavernosum endothelium: genome stability and erectile dysfunction
- Open Access
- 26 May 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (6) , e70247
Unraveling the Causal Association Between Circulating Copper Levels and Erectile Dysfunction: A Comprehensive Analysis via Bidirectional Two Sample Mendelian Randomization Study
Erectile dysfunction (ED) is a prevalent condition severely impacting men's quality of life. While micronutrient balance is critical for sexual health, observational studies on micronutrient and ED remain inconclusive. The objective of this study was to evaluate the causal role of circulating levels of copper and other micronutrients in ED risk by Mendelian randomization (MR). We conducted bidirectional two‐sample MR using summary statistics from European‐ancestry cohorts involving thirteen micronutrients. Inverse‐variance weighted (IVW) MR was complemented by sensitivity analyses, including MR‐Egger and MR‐PRESSO, and pooled analysis of two GWAS‐based datasets was performed to substantiate the findings of MR. In this study, circulating copper levels significantly increased ED risk in the discovery (OR = 1.129, 95% CI: 1.004–1.27, p = 0.042) and replication (OR = 1.115, 95% CI: 1.001–1.242, p = 0.0476) stages, as well as pooled analyses (OR = 1.122, 95% CI: 1.036–1.214, p = 0.0046). Sensitivity analyses reinforced the robustness of these findings, with no significant heterogeneity or directional pleiotropy observed. Reverse MR found no causal effect of ED on micronutrients. In summary, this study provides robust genetic evidence that elevated circulating copper levels are a modifiable risk factor for ED. Personalized management of copper intake, guided by genetic predisposition, may mitigate ED risk and improve sexual health outcomes. These findings highlight the clinical relevance of copper homeostasis in ED prevention and underscore the need for targeted nutritional interventions.
- 26 May 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (6) , e70247
Open AccessUnraveling the Causal Association Between Circulating Copper Levels and Erectile Dysfunction: A Comprehensive Analysis via Bidirectional Two Sample Mendelian Randomization Study
Erectile dysfunction (ED) is a prevalent condition severely impacting men's quality of life. While micronutrient balance is critical for sexual health, observational studies on micronutrient and ED remain inconclusive. The objective of this study was to evaluate the causal role of circulating levels of copper and other micronutrients in ED risk by Mendelian randomization (MR). We conducted bidirectional two‐sample MR using summary statistics from European‐ancestry cohorts involving thirteen micronutrients. Inverse‐variance weighted (IVW) MR was complemented by sensitivity analyses, including MR‐Egger and MR‐PRESSO, and pooled analysis of two GWAS‐based datasets was performed to substantiate the findings of MR. In this study, circulating copper levels significantly increased ED risk in the discovery (OR = 1.129, 95% CI: 1.004–1.27, p = 0.042) and replication (OR = 1.115, 95% CI: 1.001–1.242, p = 0.0476) stages, as well as pooled analyses (OR = 1.122, 95% CI: 1.036–1.214, p = 0.0046). Sensitivity analyses reinforced the robustness of these findings, with no significant heterogeneity or directional pleiotropy observed. Reverse MR found no causal effect of ED on micronutrients. In summary, this study provides robust genetic evidence that elevated circulating copper levels are a modifiable risk factor for ED. Personalized management of copper intake, guided by genetic predisposition, may mitigate ED risk and improve sexual health outcomes. These findings highlight the clinical relevance of copper homeostasis in ED prevention and underscore the need for targeted nutritional interventions.
- Open Access
- 15 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
Target sequences of shRNAs and sgRNAs used in this study.
- 15 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
Target sequences of shRNAs and sgRNAs used in this study.
- Open Access
- 15 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
Antibodies used in this study.
- 15 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
Antibodies used in this study.
- Open Access
- 15 April 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
Antibodies used in this study.
- 15 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
Antibodies used in this study.